Growth Metrics

Volitionrx (VNRX) Gains from Investment Securities (2018 - 2025)

Volitionrx filings provide 7 years of Gains from Investment Securities readings, the most recent being $50185.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 39.4% to $50185.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $151919.0, a 32.59% decrease, with the full-year FY2025 number at $2.0 million, up 1649.39% from a year prior.
  • Gains from Investment Securities hit $50185.0 in Q4 2025 for Volitionrx, down from $125000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.9 million in Q1 2025 to a low of -$13133.0 in Q2 2022.
  • Median Gains from Investment Securities over the past 5 years was $50000.0 (2023), compared with a mean of $225214.8.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 78.64% in 2024 and later soared 93564.27% in 2025.
  • Volitionrx's Gains from Investment Securities stood at $102.0 in 2021, then soared by 44442.16% to $45433.0 in 2022, then skyrocketed by 172.15% to $123647.0 in 2023, then plummeted by 33.03% to $82812.0 in 2024, then tumbled by 39.4% to $50185.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $50185.0 (Q4 2025), $125000.0 (Q3 2025), and $50000.0 (Q2 2025) per Business Quant data.